In this week’s column David Niesel and Norbert Herzog look at a new drug that is showing promise in treating those with Huntington’s disease. Huntington’s is a progressive brain disorder whose symptoms usually appear in people in their 30s or 40s and is caused by mutations in a gene called HTT. This column also published in The Galveston County Daily News.